Georgia Life Sciences Summit 2008

TUESDAY, SEPTEMBER 23, 2008

Chairman’s reception (by invitation only)

WEDNESDAY, SEPTEMBER 24, 2008

Badge Pickup
Georgia World Congress Center
Building B

Welcome and Introduction of Mayor Franklin
Thomas H. Callaway, MD; President, Life Science Partner and Managing Director, Georgia Venture Partners

Welcome
The Honorable Shirley Franklin; Mayor, City of Atlanta

Plenary Presentations
James C. Greenwood; President and Chief Executive Officer, Biotechnology Industry Organization

Tanja Popovic, MD, PhD; Chief Science Officer, U.S. Centers for Disease Control and Prevention

Stephen A. Hill, BM, BCh, MA, FRCS; President and Chief Executive Officer,
Solvay Pharmaceuticals

The Honorable Louis W. Sullivan, MD; President Emeritus, Morehouse School of Medicine

Student Business Plan Competition
Robert T. McNally, PhD; President and Chief Executive Officer, GeoVax

Exhibition and Scientific Poster Viewing

MORNING CONCURRENT FOCUS SESSION
(Click on the title of each session for its description)

Ia. Forces Shaping the Emerging Bioeconomy in Agriculture

Clifton A. Baile, PhD; Moderator, Georgia Research Alliance Eminent Scholar in Agricultural Biotechnology and Distinguished Professor of Animal Science and Foods and Nutrition,
University of Georgia

Gregg W. BeVier, DVM, MBA; Moderator, Chief Executive officer, AgGlobalVision

Dennis T. Avery; Senior Fellow of the Hudson Institute and Director of its Center for Global Food Issues

Joseph C. Moran; Senior Division Vice President Fresh Foodservice Division, Pilgrim’s Pride Corporation

Michael C. Robach; Vice President, Corporate Food Safety & Regulatory Affairs, Cargill, Incorporated

Ib.

Traversing the Regulatory & Clinical Compliance Maze: From Preclinical to Market Approval

David W. Mullis, Jr., PhD, RAC; Moderator, Mullis & Associates

Stephanie E. Hubbard; Bioresearch Monitoring Specialist, Food and Drug Administration

Alan G. Minsk; Partner and Chair of the Food & Drug Practice Team,
Arnall Golden Gregory LLP

Mamta Trivedi; Global Senior Director, QLAB, Global Quality Assurance, Central Labs, Quintiles Transnational Corp.

Ic. The Next Generation of Georgia’s Life Science Companies

H. Lee Herron, DVM; Moderator, Vice President of Commercialization,
Georgia Research Alliance

Id. Cardiovascular Innovation in Public-Private Partnerships

Jay S. Yadav, MD; Moderator, Chairman and Chief Executive Officer, CardioMEMS

Todd T. Sherer, PhD; Moderator, Associate Vice President for Research and Director,
Office of Technology Transfer, Emory University

Nic Chronos, MD; Chief Medical and Scientific Officer, Saint Joseph’s Translational
Research Institute

Omar M. Lattouf, MD, PhD, FACS,FACC; Associate Professor of Surgery / Cardiothoracic, Emory University. Inventor, Founder and Principal of TransCardiac Therapeutics, Inc.

Michele M. Molden; President and Chief Executive Officer, Piedmont Heart Institute

David L. West, PhD, MPH; Vice President, Medical Device Development, Quintiles Consulting

Lunch

Research Advances in Georgia: Neuroscience

Georgia Life Sciences Summit 2008

Research Advances in Georgia: Neuroscience
Neuroscience is one of the strongest areas of interdisiciplinary and inter-institutional research in Georgia. This research is pushing the envelope on one of science's last and most daunting frontiers — the brain. This work holds great promise for understanding basic brain function and treating illnesses such as Alzheimer's disease and post traumatic stress disorder. The Center for Behavioral Neuroscience will host this plenary session where speakers will discuss recent advances in neuroscience research from the laboratories of scientists at Georgia’s research universities.

H. Elliott Albers, PhD; Moderator, Regents Professor, Georgia State University, Director, Center for Behavioral Neuroscience

Dennis W. Choi, MD, PhD; Executive Director, Professor of Neurology, Pharmacology, and Biology, Emory University

Stephen P. DeWeerth, PhD; Professor and Associate Chair for Graduate Studies Wallace H. Coulter Department of Biomedical Engineering School of Electrical and Computer Engineering, Georgia Tech/Emory University

Gaylen L. Edwards, DVM, PhD; Professor and Department Head, Department of Physiology and Pharmacology College of Veterinary Medicine, The University of Georgia

Peter R. MacLeish, PhD; Director Neuroscience Institute, Morehouse School of Medicine

Walt Wilczynski, PhD; Professor of Psychology, Director, Neuroscience Institute, Center for Behavioral Neuroscience, Georgia State University

Robert K. Yu, PhD, MedScD; Professor and Director, Institute of Molecular Medicine & Genetics, Medical College of Georgia

Student Business Plan Competition
Robert T. McNally, PhD; President and Chief Executive Officer, GeoVax

Exhibition and Scientific Poster Viewing

Afternoon Concurrent Focus Session
(Click on the title of each session for its description)

IIa.

Medical Devices in Georgia
presented in partnership with the Southeast Medical Device Association

John G. Edwards; Moderator, Chief Executive Officer, Apeliotus Technologies

Why Medical Devices are Hot

Keith Barritt; Prinicpal, Fish & Richardson PC

Ted Davis; Vice President, Business Development, Wright Medical Group

Al Lauritano; Director, Business Development, BD Technologies

Georgia Makes its Mark in Medical Devices

Mark J. Phelps, PhD.; Senior Vice President of Research and Development,
LIFESYNC Incorporated

Brian Walsh; President, Dornier MedTech America

Lynn Winterton; Global Head of Research, CIBA Vision

IIb.

“Delivering the Golden Egg” - IPOs, M&A and Partnering in the Life Sciences Industry

Howard D. Palefsky; Moderator, General Partner/Managing Member Montreux Equity Partners

Steven P. Damon; Vice President, Business Development, Altea Therapeutics

Randy Guggenheimer; Managing Director, Burrill & Company

Bruce C. Robertson, PhD; Managing Director, H.I.G. Ventures

John W. Sharkey, PhD; Vice President, Business Development, Sciele Pharma, Inc

IIc. Bioenergy: A Fuel for Success

Jill Stuckey; Moderator, Director, Georgia Energy Innovation Center

Nathan McClure; Moderator, Director of Fore

Georgia Life Sciences Summit 2008

CONCURRENT FOCUS SESSION *IIb. “Delivering the Golden Egg” - IPOs, M&A and Partnering in the Life Sciences Industry*
Investors put money into emerging life science companies expecting to profitably take money out later. This “exit” ordinarily takes the form of either going public or being acquired by a larger company. What is the current status of IPOs and M&A in the industry? And how does partnering affect the eventual exit for a company? Our panel of industry experts will provide up-to-date insights.

st Energy and Development,
Georgia Forestry Commission

James Fang, PhD; Director of Engineering, Sriya Innovations, Inc.

Joy Doran Peterson, PhD; Assistant Professor of Microbiology,
The University of Georgia

Bill Schafer; Senior Vice President of Business Development, Range Fuels, Inc.

IId.

Why Georgia?: The Ascent and Maturation of Georgia's Talent Pool and Biotech Labor Market presented by The GaBio Emerging Leaders Network

Blaine W. Lindsey; Moderator, Attorney at Law, Representative, GaBio Emerging Leaders Network

Mark Banks; Vice President of Human Resources, Sciele Pharma, Inc

Amanda DePalma; Director, Global Strategic Marketing, Kimberly-Clark Health Care

Jeffrey M. Humphreys; Director, Selig Center, Terry College of Business,
The University of Georgia

Keynote Address
The Honorable Sonny Perdue, DVM; Governor, State of Georgia (invited)

Georgia Bio Honors Senator Bob Dole for His Contribution to University-based Innovation
Senator Bob Dole; Special Counsel, Alston & Bird

28 Years of Impact: The Bayh-Dole Act Accelerated the Realization of Georgia’s Biotechnology Economy

C. Michael Cassidy; President and Chief Executive Officer, Georgia Research Alliance

James C. Greenwood; President and Chief Executive Officer, Biotechnology Industry Organization

Concluding Comments
Senator Bob Dole; Special Counsel, Alston & Bird

Announcement of Poster Winners

Anthony J. Shuker, PhD; Moderator

David Wynes, PhD; Moderator, Vice President for Research Administration,
Emory University

Closing Remarks
Thomas H. Callaway, MD; President, Life Science Partner and Managing Director, Georgia Venture Partners

Gala Party
Georgia World Congress Center
Building A: Rooms 311-314

CONCURRENT FOCUS SESSION Ia. Forces Shaping the Emerging Bioeconomy in Agriculture
Global agriculture is at a defining moment. Society looks to policy makers and leadership groups in agriculture to develop solutions for world hunger, biofuels, drought and management of water resources, zoonotic and pandemic diseases, scarce land resources and a safe food supply. Agriculture is in a key position to provide these solutions as long as technology is adopted and optimally used. During this session, you will hear some of the leaders in Agribusiness speak on how they are positioning their organizations for winning solutions and strategies to meet these challenges.

CONCURRENT FOCUS SESSION *Ic.* The Next Generation of Georgia’s Life Science Companies
Georgia is home to some of the leading young companies in the life science industry. This session will feature presentations by some of our most innovative emerging companies. This group of companies provides a window into the future of the life science industry in Georgia and the Southeast.

CONCURRENT FOCUS SESSION *IId. Why Georgia?: The Ascent and Maturation of Georgia's Talent Pool and Biotech Labor Market presented by The GaBio Emerging Leaders Network*
The first question a biotech business asks before locating in a certain region is often: "Is there a large, educated, and specialized workforce in place to support our firm?" Likewise, the first question a young biotech professional asks when choosing a market is: "Is there sufficient opportunity for advancement towards a meaningful career?" For the first time, the answer to both of those questions in Georgia is an unequivocal "Yes!" In this session, leading economic experts will discuss Georgia's human resources economics, and some of the region's leading companies will discuss the arrival of Georgia as a mature hotbed of talent competitive with any other U.S. market.

CONCURRENT FOCUS SESSION *IIc.* *Bioenergy: A Fuel for Success*
As oil prices continue to rise and concerns of greenhouse gas emissions become more serious, Georgia pine pine forests are poised to provide relief for these energy and environmental concerns. Georgia is uniquely positioned to be a leader in the production of pine biomass and commercializing a cellulosic fuels industry. Speakers will discuss the latest advances in technology, status of the developing industry, and the benefits to our region.

CONCURRENT FOCUS SESSION *IIa. Medical Devices in Georgia*
“Why Medical Devices are Hot” – This segment will explore some of the reasons that medical devices are strong in today’s market, including attractive investment/return dynamics, strong options for exits, and recent Supreme Court decisions (Riegel v. Medtronic, Warner-Lambert v. Kent) that shield FDA approved medical devices from liability claims at the state level. "Georgia Makes its Mark in Medical Devices” – This segment will present three Georgia medical device company success stories.

CONCURRENT FOCUS SESSION *Id.* *Cardiovascular Innovation in Public-Private Partnerships*
Cardiovascular disease remains the nation’s number one health care problem and Georgia has some of the highest rates in the country for heart disease, stroke and hypertension. There is a need not only for new technologies for cardiovascular disease but also for new delivery and business models that can function in the rapidly changing and increasingly challenging regulatory and reimbursement environment. Atlanta doctors, institutions, and universities have been at the forefront of both technological and programmatic solutions. This panel will bring together some of these key innovators in cardiology and cardiac surgery as well as administrators from the region’s leading cardiovascular institutions to discuss these challenges. Issues and challenges surrounding the use of public/private partnerships to bring new products to market will also be addressed.

CONCURRENT FOCUS SESSION *Ib. Traversing the Regulatory & Clinical Compliance Maze: From Preclinical to Market Approval*
The focus of this breakout session is to address 1) Working/Communicating Effectively with FDA; 2) Overview of Regulatory Submissions; and 3) Clinical Trials--Common Pitfalls & Challenges.